Respiratory News and Research

RSS

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

Researchers at Karolinska Institutet in Sweden have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.

10 Jan 2024

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy.

10 Jan 2024

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Study reveals that the Omicron subvariants BA.2.86 and FLip show unique mutations and infectivity profiles, with BA.2.86 being highly infectious and resistant to most conventional antibodies, underscoring the need for updated vaccines.

9 Jan 2024

Acute hospital at home model shows promise for boosting patient satisfaction and outcomes

Since the Centers for Medicare and Medicaid Services launched the Acute Hospital Care at Home (AHCaH) Waiver in 2020, thousands of patients from across 300 hospitals in 37 states have been treated in their homes.

9 Jan 2024

Universal consensus definition unlocks research advancements for critically ill children worldwide

St. Jude Children's Research Hospital investigators collaborated with a global group of acute pediatric critical illness experts to reach a consensus definition of the condition.

9 Jan 2024

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S..

From QIAGEN Manchester Limited 9 Jan 2024

Do e-health interventions for smoking cessation management work?

Efficacy of e-health interventions for smoking cessation management in smokers.

9 Jan 2024

Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

9 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts.

8 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024

Scientists unveil the hidden respiratory mechanisms of gut bacteria

Study explores the use of respiratory electron acceptors by diverse gut bacteria, revealing a novel type of anaerobic respiration linked to the gut metabolome and microbial energy metabolism.

8 Jan 2024

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

Study investigates the pathophysiology of post-exertional malaise in long COVID patients, revealing skeletal muscle changes, exercise capacity reduction, metabolic disturbances, and tissue alterations.

8 Jan 2024

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

It's winter, that cozy season that brings crackling fireplaces, indoor gatherings — and a wave of respiratory illness.

8 Jan 2024

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Study challenges the hypothesis of genetic recombination in SARS-CoV-2's evolution, suggesting its ancestral virus already possessed human-infecting traits, based on analyses of over 100 viral genomes.

7 Jan 2024

Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

7 Jan 2024

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

The UK Health Security Agency (UKHSA) is reminding all those eligible that it's not too late to book their flu and COVID-19 vaccinations.

5 Jan 2024

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

Trends in places of death across 32 countries during and before the COVID-19.

5 Jan 2024

Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression

A study analyzing data from the Genitourinary Medicine Clinic Activity Dataset in England shows a 64% increase in gonorrhea diagnoses following the relaxation of COVID-19 restrictions, despite only a 5.6% increase in STI testing, suggesting that social distancing may have suppressed STI transmission.

4 Jan 2024

Respiratory News and Research

Nasal drops with IgA antibodies may protect against COVID-19 and future variants

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New Omicron subvariants test vaccine limits, reveal unique infection challenges

Acute hospital at home model shows promise for boosting patient satisfaction and outcomes

Universal consensus definition unlocks research advancements for critically ill children worldwide

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

Do e-health interventions for smoking cessation management work?

Infammasomes provide a therapeutic target against human diseases

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Scientists unveil the hidden respiratory mechanisms of gut bacteria

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Genetic keys to COVID-19 vaccine response unlocked

Stapled lipopeptides show promise as broad-spectrum antiviral agents

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

Gonorrhea cases surge 64% post-COVID lockdown in England, highlighting unintended STI suppression

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News